Jonathan H. Kaufman - 15 Mar 2024 Form 4 Insider Report for LIPELLA PHARMACEUTICALS INC. (LIPO)

Role
President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors, Director, 10%+ Owner
Signature
/s/ Jonathan H. Kaufman
Issuer symbol
LIPO
Transactions as of
15 Mar 2024
Net transactions value
+$45,452
Form type
4
Filing time
19 Mar 2024, 18:21:08 UTC
Previous filing
15 Mar 2024
Next filing
15 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIPO Common Stock Purchase $23,649 +30,000 +3.6% $0.7883 863,849 18 Mar 2024 Direct F1, F2, F3
transaction LIPO Common Stock Purchase $21,802 +25,000 +2.9% $0.8721 888,849 19 Mar 2024 Direct F3, F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIPO Stock Options Award $0 +80,000 $0.000000 80,000 15 Mar 2024 Common Stock 80,000 $0.7700 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Open market purchase by the reporting person of 30,000 shares of common stock, par value $0.0001 per share (the "Common Stock").
F2 Reflects the weighted average price of the shares purchased on the open market in multiple transactions on March 18, 2024 at prices ranging from $0.77 to $0.80 per share, inclusive.
F3 The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.
F4 Open market purchase by the reporting person of 25,000 shares of Common Stock.
F5 Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on March 19, 2024 at prices ranging from $0.75 to $0.89 per share, inclusive.

Remarks:

President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors